
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Degradation of Hexokinase 2 Blocks Glycolysis and Induces GSDME-Dependent Pyroptosis to Amplify Immunogenic Cell Death for Breast Cancer Therapy
Ruoxi Sang, Renming Fan, Aohua Deng, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 13, pp. 8464-8483
Closed Access | Times Cited: 28
Ruoxi Sang, Renming Fan, Aohua Deng, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 13, pp. 8464-8483
Closed Access | Times Cited: 28
Showing 1-25 of 28 citing articles:
Thermal Proteome Profiling Strategy Identifies CNPY3 as a Cellular Target of Gambogic Acid for Inducing Prostate Cancer Pyroptosis
Xiaowen Zhang, Ling Li, Min Liao, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 12, pp. 10005-10011
Closed Access | Times Cited: 17
Xiaowen Zhang, Ling Li, Min Liao, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 12, pp. 10005-10011
Closed Access | Times Cited: 17
ASF1A-dependent P300-mediated histone H3 lysine 18 lactylation promotes atherosclerosis by regulating EndMT
Mengdie Dong, Yunjia Zhang, Minghong Chen, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 7, pp. 3027-3048
Open Access | Times Cited: 12
Mengdie Dong, Yunjia Zhang, Minghong Chen, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 7, pp. 3027-3048
Open Access | Times Cited: 12
Transcriptional regulation and post-translational modifications in the glycolytic pathway for targeted cancer therapy
Xuan Ni, Chengpiao Lu, Guo-qiang Xu, et al.
Acta Pharmacologica Sinica (2024) Vol. 45, Iss. 8, pp. 1533-1555
Closed Access | Times Cited: 10
Xuan Ni, Chengpiao Lu, Guo-qiang Xu, et al.
Acta Pharmacologica Sinica (2024) Vol. 45, Iss. 8, pp. 1533-1555
Closed Access | Times Cited: 10
Therapeutic strategies of targeting non-apoptotic regulated cell death (RCD) with small-molecule compounds in cancer
Xin Jin, Wenke Jin, L. Tong, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 7, pp. 2815-2853
Open Access | Times Cited: 8
Xin Jin, Wenke Jin, L. Tong, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 7, pp. 2815-2853
Open Access | Times Cited: 8
Targeting the mevalonate pathway potentiates NUAK1 inhibition-induced immunogenic cell death and antitumor immunity
Liming Gui, Kaiwen W. Chen, Jingjing Yan, et al.
Cell Reports Medicine (2025), pp. 101913-101913
Open Access | Times Cited: 1
Liming Gui, Kaiwen W. Chen, Jingjing Yan, et al.
Cell Reports Medicine (2025), pp. 101913-101913
Open Access | Times Cited: 1
Construction and in vitro evaluation of pH-sensitive nanoparticles to reverse drug resistance of breast cancer stem cells
Weinan Li, Yuhan Fu, Jialin Sun, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6
Weinan Li, Yuhan Fu, Jialin Sun, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6
Journey of Von Hippel-Lindau (VHL) E3 ligase in PROTACs design: From VHL ligands to VHL-based degraders
Nisha Setia, Haider Thaer Abdulhameed Almuqdadi, Mohammad Abid
European Journal of Medicinal Chemistry (2023) Vol. 265, pp. 116041-116041
Closed Access | Times Cited: 14
Nisha Setia, Haider Thaer Abdulhameed Almuqdadi, Mohammad Abid
European Journal of Medicinal Chemistry (2023) Vol. 265, pp. 116041-116041
Closed Access | Times Cited: 14
Unraveling the underlying mechanisms of cancer stem cells in therapeutic resistance for optimizing treatment strategies
Yunhan Tan, Siyuan Qin, Zhe Zhang, et al.
MedComm – Oncology (2025) Vol. 4, Iss. 1
Open Access
Yunhan Tan, Siyuan Qin, Zhe Zhang, et al.
MedComm – Oncology (2025) Vol. 4, Iss. 1
Open Access
Activation of mTOR/HK2 Signaling Mitigates Effects of PYCR2 Depletion in Colorectal Cells
Li Chen, Yuan Yuan, Nian Zhang, et al.
Tissue and Cell (2025) Vol. 93, pp. 102729-102729
Open Access
Li Chen, Yuan Yuan, Nian Zhang, et al.
Tissue and Cell (2025) Vol. 93, pp. 102729-102729
Open Access
A novel small molecule NJH-13 induces pyroptosis via the Ca2+ driven AKT-FOXO1-GSDME signaling pathway in NSCLC by targeting TRPV5
Xianxiang Dong, Jiahui Nie, Aijun Huang, et al.
Journal of Advanced Research (2025)
Open Access
Xianxiang Dong, Jiahui Nie, Aijun Huang, et al.
Journal of Advanced Research (2025)
Open Access
The role of circular RNAs in glucose metabolic reprogramming: impact on cancer progression and therapeutic implications in breast cancer
Yiran Liang, Qifeng Yang
Journal of Cancer Metastasis and Treatment (2025)
Open Access
Yiran Liang, Qifeng Yang
Journal of Cancer Metastasis and Treatment (2025)
Open Access
Macrocyclic Peptide-Based Dual-Sensor Platform for Linkage-Specific Visualization of Ubiquitin Chain Assembling in Live Cells
Han Gao, Zhirong He, Jian Chen, et al.
Analytical Chemistry (2025)
Closed Access
Han Gao, Zhirong He, Jian Chen, et al.
Analytical Chemistry (2025)
Closed Access
Simultaneous Induction of Immunogenic Pyroptosis and PD-L1 Downregulation by One Single Photosensitizer for Synergistic Cancer Photoimmunotherapy
Weijia Chen, Jingru Qiu, Peixia Li, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Weijia Chen, Jingru Qiu, Peixia Li, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Carbohydrate kinase inhibition: a promising strategy in cancer treatment
Amita Jain, Rudradip Das, Monalisha Giri, et al.
Drug Discovery Today (2025), pp. 104308-104308
Closed Access
Amita Jain, Rudradip Das, Monalisha Giri, et al.
Drug Discovery Today (2025), pp. 104308-104308
Closed Access
Newcastle Disease Virus Induces Pyroptosis in Canine Mammary Tumour CMT ‐U27 Cells via the TNFα /NF ‐κB /NLRP3 Signalling Pathway
Mengqing Li, Yunjie Zhu, Meng Li
Veterinary and Comparative Oncology (2025)
Closed Access
Mengqing Li, Yunjie Zhu, Meng Li
Veterinary and Comparative Oncology (2025)
Closed Access
The Significance of Microenvironmental and Circulating Lactate in Breast Cancer
Vincenza Frisardi, Simone Canovi, Salvatore Vaccaro, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 20, pp. 15369-15369
Open Access | Times Cited: 11
Vincenza Frisardi, Simone Canovi, Salvatore Vaccaro, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 20, pp. 15369-15369
Open Access | Times Cited: 11
Discovery of novel quinoline scaffold selective estrogen receptor degraders (SERDs) for treatment of ER positive breast cancer with enhanced antiproliferative bioactivity through immunogenic cell death (ICD) effects
Yunlong Lu, Zhenlin Liang, Lijuan Liu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 275, pp. 116534-116534
Closed Access | Times Cited: 3
Yunlong Lu, Zhenlin Liang, Lijuan Liu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 275, pp. 116534-116534
Closed Access | Times Cited: 3
Paclitaxel-resistance facilitates glycolytic metabolism via Hexokinase-2-regulated ABC and SLC transporter genes in ovarian clear cell carcinoma
Tsai‐Yu Lin, Shin‐Yuan Gu, Yi-Hui Lin, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 180, pp. 117452-117452
Open Access | Times Cited: 2
Tsai‐Yu Lin, Shin‐Yuan Gu, Yi-Hui Lin, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 180, pp. 117452-117452
Open Access | Times Cited: 2
Pyroptosis: Induction and inhibition strategies for immunotherapy of diseases
Junjun Wu, Hong Wang, Pu Gao, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 10, pp. 4195-4227
Open Access | Times Cited: 1
Junjun Wu, Hong Wang, Pu Gao, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 10, pp. 4195-4227
Open Access | Times Cited: 1
Decoding cell death signalling: Impact on the response of breast cancer cells to approved therapies
Lama Lozon, Wafaa S. Ramadan, Rawan R. Kawaf, et al.
Life Sciences (2024) Vol. 342, pp. 122525-122525
Closed Access | Times Cited: 1
Lama Lozon, Wafaa S. Ramadan, Rawan R. Kawaf, et al.
Life Sciences (2024) Vol. 342, pp. 122525-122525
Closed Access | Times Cited: 1
Discovery of novel KSP-targeting PROTACs with potent antitumor effects in Vitro and in Vivo
Deng‐Gao Zhao, J. Y. Liu, Zhiguang Su, et al.
European Journal of Medicinal Chemistry (2024) Vol. 282, pp. 117052-117052
Closed Access | Times Cited: 1
Deng‐Gao Zhao, J. Y. Liu, Zhiguang Su, et al.
European Journal of Medicinal Chemistry (2024) Vol. 282, pp. 117052-117052
Closed Access | Times Cited: 1
Cascaded Antitumor Therapy Excited by Dual Nanozymes Based on Energy Restriction and Photocatalysis
Zhuo Li, Jiaxin Bian, Zichuang Xu, et al.
ACS Applied Materials & Interfaces (2023)
Closed Access | Times Cited: 3
Zhuo Li, Jiaxin Bian, Zichuang Xu, et al.
ACS Applied Materials & Interfaces (2023)
Closed Access | Times Cited: 3
Targeting mitochondrial damage: shining a new light on immunotherapy
Wenjuan Zeng, Menghui Wang, Yuxin Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Wenjuan Zeng, Menghui Wang, Yuxin Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Research progress on the effect of pyroptosis on the occurrence, development, invasion and metastasis of colorectal cancer
Xu Wang, Qi-Hang Yin, Lin-Lu Wan, et al.
World Journal of Gastrointestinal Oncology (2024) Vol. 16, Iss. 8, pp. 3410-3427
Open Access
Xu Wang, Qi-Hang Yin, Lin-Lu Wan, et al.
World Journal of Gastrointestinal Oncology (2024) Vol. 16, Iss. 8, pp. 3410-3427
Open Access
Comprehensive review of drug-mediated ICD inhibition of breast cancer: mechanism, status, and prospects
Yang Wang, Rui Yang, Ying Xie, et al.
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access
Yang Wang, Rui Yang, Ying Xie, et al.
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access